Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Firestone

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Bioconjugate Chemistry|July 18, 2002
Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activityGene M Dubowchik, Raymond A Firestone, Linda Padilla, et al.
Journal of the American Chemical Society|May 25, 2006
Antiparallel-aligned neutral-ground-state and zwitterionic chromophores as a nonlinear optical materialYi Liao, Sanchali Bhattacharjee, Kimberly A Firestone, et al.
Molecular Cancer|March 5, 2014
Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicityLi Tang, Rui Duan, Yan-jun Zhong, et al.
Faraday Discussions|September 29, 2017
Design principles from multiscale simulations to predict nanostructure in self-assembling ionic liquidsBenjamin T Nebgen, Harsha D Magurudeniya, Kevin W C Kwock, et al.
Bioconjugate Chemistry|November 1, 1993
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 31, 2006
Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalenceSimon D W Frost, Kimberly C Brouwer, Michelle A Firestone Cruz, et al.
Nature|May 7, 1987
Crystallographic study of a beta-lactam inhibitor complex with elastase at 1.84 A resolutionM A Navia, J P Springer, T Y Lin, et al.
Journal of Translational Medicine|August 22, 2013
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical studyQun Wang, Yan-Jun Zhong, Jing-Ping Yuan, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkagesGene M Dubowchik, Shilpa Radia, Harold Mastalerz, et al.
Journal of Medicinal Chemistry|May 1, 1982
Lysosomotropic agents. 4. Carbobenzoxyglycylphenylalanyl, a new protease-sensitive masking group for introduction into cellsR A Firestone, J M Pisano, P J Bailey, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Bioconjugate Chemistry|July 18, 2002
Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activityGene M Dubowchik, Raymond A Firestone, Linda Padilla, et al.
Journal of the American Chemical Society|May 25, 2006
Antiparallel-aligned neutral-ground-state and zwitterionic chromophores as a nonlinear optical materialYi Liao, Sanchali Bhattacharjee, Kimberly A Firestone, et al.
Molecular Cancer|March 5, 2014
Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicityLi Tang, Rui Duan, Yan-jun Zhong, et al.
Faraday Discussions|September 29, 2017
Design principles from multiscale simulations to predict nanostructure in self-assembling ionic liquidsBenjamin T Nebgen, Harsha D Magurudeniya, Kevin W C Kwock, et al.
Bioconjugate Chemistry|November 1, 1993
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 31, 2006
Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalenceSimon D W Frost, Kimberly C Brouwer, Michelle A Firestone Cruz, et al.
Nature|May 7, 1987
Crystallographic study of a beta-lactam inhibitor complex with elastase at 1.84 A resolutionM A Navia, J P Springer, T Y Lin, et al.
Journal of Translational Medicine|August 22, 2013
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical studyQun Wang, Yan-Jun Zhong, Jing-Ping Yuan, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkagesGene M Dubowchik, Shilpa Radia, Harold Mastalerz, et al.
Journal of Medicinal Chemistry|May 1, 1982
Lysosomotropic agents. 4. Carbobenzoxyglycylphenylalanyl, a new protease-sensitive masking group for introduction into cellsR A Firestone, J M Pisano, P J Bailey, et al.
Pageof 12